DOW CORNING NOTIFICATION PROGRAM TARGETS OVER 900,000 POTENTIAL CLAIMANTS IN U.S.; DIRECT MAILING COVERS ALL IMPLANTS USING DOW CORNING SILICONE
This article was originally published in The Gray Sheet
Dow Corning is mailing notification packages to more than 900,000 individuals in the U.S. who have been identified as potential product liability claimants, the firm states. An additional 90,000 individuals residing outside of the U.S. also will receive the initial mailings.
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.